Trials / Unknown
UnknownNCT05662163
Effect of General Anesthesia Method on Cardiac Risk Patients on Ischemia Modified Markers
Effect of General Anesthesia Method Chosen in Non-cardiac Surgery of Cardiac Risk Patients on Ischemia Modified Albumin and Heart-Type Fatty Acid-Binding Protein (H-FABP) Levels
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Ataturk University · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
To examine the effects of the general anesthesia method chosen in non-cardiac surgical operations of patients with cardiac risk on the levels of cardiac markers
Detailed description
To examine the effects of the general anesthesia method chosen in non-cardiac surgical operations of patients with cardiac risk on the levels of cardiac markers like; serum levels of the Creatine Kinase, Creatine Kinase Myocardial Band, high sensitive troponin, heart-type fatty acid-binding protein, ischemia-modified albumin and albumin. And evaluate the effect of anesthesia method on haemodynamic.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | TIVA | Anesthesia will be maintained with propofol (6-10 mg/kg/hour) and remifentanil (0.1-0.3 μg/kg/min). |
| PROCEDURE | GENERAL ANESTHESIA | Anesthesia will be maintained with sevoflurane (2 ml/min) 50% oxygen and remifentanil (0.1-0.3 μg/kg/min). |
Timeline
- Start date
- 2022-12-30
- Primary completion
- 2023-06-30
- Completion
- 2023-12-30
- First posted
- 2022-12-22
- Last updated
- 2022-12-22
Source: ClinicalTrials.gov record NCT05662163. Inclusion in this directory is not an endorsement.